跳至主要内容
临床试验/NCT05483140
NCT05483140已完成不适用

Assessing The Effectiveness of A Digitally Enabled Low Energy Diet on Type 2 Diabetes Management

Abbott Nutrition4 个研究点 分布在 1 个国家目标入组 217 人开始时间: 2022年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
217
试验地点
4
主要终点
Program Feasibility

研究概览

简要总结

The study (known as clinical audit in UK) will observe and report on a digitally-enabled structured weight management program including use of a meal replacement on clinical and economic outcomes for community-dwelling adults living with type 2 diabetes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have a clinical diagnosis of T2DM within the last 6 years
  • Aged 20 - 70 years
  • Have a BMI ≥ 27 kg/m2
  • HbA1c ≥ 48 mmol/mol (≥ 42mmol/mol if prescribed glucose-lowering agents)
  • Have access to the internet and a computer, smartphone or tablet
  • Ability to read and understand English
  • Willing to provide individual consent

排除标准

  • Current insulin use
  • More than two anti-hyperglycemic agents prescribed
  • Recent routine HbA1c ≥ 90 mmol/mol
  • Diagnosed with moderate or severe frailty
  • Diagnosed eating disorder or purging
  • Unable or unwilling to tolerate soy/milk-based meal replacements
  • Myocardial infarction within last 6 months
  • Recent eGFR <30 ml/min/1.73 m2
  • Prescribed SGLT2 inhibitor for diabetic kidney disease (DKD) or left ventricular hypertrophy (LVH)
  • Severe heart failure defined as equivalent to the New York Heart Association grade 3 (NYHA)
  • Current treatment with anti-obesity drugs
  • Learning difficulties that would prevent engagement with the program
  • Having required hospitalization for depression or being prescribed antipsychotic drugs
  • Known cancer
  • Active substance misuse
  • Contraindications to exercise
  • Contraindications to lose weight
  • Mental or physical incapacity that makes self-management inappropriate
  • Pregnant, planning a pregnancy or lactating
  • Currently undergoing palliative care
  • Previous bariatric surgery or on waiting list for bariatric surgery (unless willing to come off waiting list)
  • Unable to commit to long term lifestyle change
  • Known proliferative retinopathy that has not been treated

结局指标

主要结局

Program Feasibility

时间窗: Baseline to 12 Months

Participant and HCP completed program questionnaire scored from 0 to 10 where higher score is more favorable

Program Effectiveness

时间窗: Baseline to 12 Months

Mean Weight Change

次要结局

  • Glycemic Control(Baseline to 12 Months)
  • Diabetes Distress(Baseline to 12 Months)
  • Medication Usage use(Baseline to 12 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验